Download the NSCLC resource guide for an outline of TNM staging, treatment by cancer stage, initial systemic therapy, emerging biomarkers, targeted therapy, EGFR TKI toxicity, MASCC rash prevention, and survivorship care.

This clinician resource guide outlines IWG Descriptive Terminology, diagnosis, first-line treatment, subsequent management, and special considerations for immune thrombocytopenia. Download the guide today!

This clinician resource guide discusses grading, Ann Arbor classification, diagnostic workup, FLIPI risk factors, personalized care planning, and novel therapeutic approaches for relapsed/refractory FL. Download the guide!

This case-based discussion led by Morie A. Gertz, MD, MACP and Toni Dubeau, RN, NP discusses risk stratification, novel therapeutic approaches, and adverse event management strategies. Complete the activity & download the clinician's resource guide!

Patients with TNBC have a poorer prognosis than those who present with HR-positive or HER2-positive disease. This CME/CE-approved discussion on metastatic TNBC with Sara Tolaney, MD, MPH and Sara Hurvitz, MD will evaluate personalized care plans, genetic risk evaluation, and novel therapies.

This clinician's resource guide outlines risk factors and classification, signs and symptoms of clinical TLS, and the Cairo-Bishop classification of adult TLS. Download now!

This case-based discussion on metastatic gastric cancer features Jaffer A. Ajani, MD and Allyson J. Ocean, MD as they examine individualized treatment selection, novel therapies, and adverse event management. Download the clinician's resource guide today!

This online strategy session features a discussion between Stephanie Jackson, MSN, RN, AOCNS, BMTCN and Leslie Smith, RN, APRN-CNS, AOCNS on CAR T-cell therapy in patients with B-cell malignancies such as T-cell workflow, efficacy and safety data, as well as adverse event management.

In this case-based activity, Alicia K. Morgans, MD, MPH and Tanya Dorff, MD discuss predictive and prognostic markers, recent findings, novel treatments, and supportive care plans for patients with castration-resistant prostate cancer.

In this online activity, Craig H. Moskowitz, MD and Kami Maddocks, MD discuss factors that increase risk for cHL treatment failure, emerging data on the treatment of newly diagnosed and relapsed/refractory cHL, and assess strategies to manage toxicities associated with therapy.

This clinician's resource guide outlines initial tests for diagnosis, staging, treatments, combination therapies, stem cell transplant, and supportive care for patients with multiple myeloma. Download the guide today!